Arcellx

Office Manager

Rockville, Maryland, United States

$60,000 – $80,000Compensation
Mid-level (3 to 4 years), Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Administrative Support, Facilities ManagementIndustries

Requirements

Candidates should possess a minimum of 5 years of experience in a similar role involving facilities management, including oversight of daily office operations, administrative processes, and vendor relationships. They should also demonstrate experience in ensuring adherence to company safety standards and visitor protocols, as well as coordinating company events and travel arrangements.

Responsibilities

The Office Manager will oversee the daily operations of the office, including facility-related functions and administrative processes, serve as the primary point of contact for internal departments and external vendors, provide high-level administrative support to executive team members, ensure adherence to company safety standards and visitor protocols, regularly communicate updates to stakeholders, perform functions to plan and manage facilities, systems, equipment, and utilities, create and process purchase orders, oversee administrative functions such as scheduling and inventory management, and support People functions including onboarding and building access.

Skills

Facilities Management
Vendor Relations
Administrative Support
Safety Standards
Visitor Protocols
Event Coordination
Travel Arrangements
Purchase Orders
Scheduling
Inventory Management
Communication
Stakeholder Management
Facilities Planning
Equipment Management
Utilities Management

Arcellx

Develops immunotherapies for cell therapy

About Arcellx

Arcellx develops immunotherapies aimed at improving cell therapy for serious diseases. Their products focus on advanced techniques that enhance the effectiveness of treatments. The company collaborates with healthcare providers and research institutions to bring these therapies to patients. Unlike many competitors, Arcellx emphasizes proprietary products and partnerships to drive their research and development efforts. The goal is to meet unmet medical needs by providing safe and effective treatment options through their innovative approach to cell therapy.

Key Metrics

Gaithersburg, MarylandHeadquarters
2014Year Founded
$194.5MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Unlimited Paid Time Off
Flexible Work Hours
401(k) Company Match
Fully-Paid Parental Leave
Tuition Reimbursement
Relocation Assistance

Risks

Competition from established CAR-T therapies like Abecma and Carvykti could limit market share.
Dependency on Gilead's Kite partnership poses risks if partnership dynamics change.
Phase 3 iMMagine-3 trial delays or failures could impact anito-cel's market timeline.

Differentiation

Arcellx's CART-ddBCMA has FDA Fast Track and Orphan Drug designations.
The novel D-Domain binder in anito-cel enhances antigen binding and cell killing.
ARC-SparX offers dosable and controllable CAR-T therapy options.

Upsides

Growing investment in personalized medicine aligns with Arcellx's tailored immunotherapies.
Advancements in gene editing like CRISPR enhance precision in engineered cell therapies.
Outpatient CAR-T administration could reduce costs and increase accessibility for Arcellx.

Land your dream remote job 3x faster with AI